CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 63 filers reported holding CUE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $722,170 | +11.3% | 313,987 | +76.6% | 0.00% | – |
Q2 2023 | $649,120 | +52674.0% | 177,841 | -48.4% | 0.00% | -100.0% |
Q1 2023 | $1,230 | +15.4% | 344,612 | -7.9% | 0.00% | 0.0% |
Q4 2022 | $1,066 | -99.9% | 373,982 | -15.1% | 0.00% | 0.0% |
Q3 2022 | $982,000 | -34.5% | 440,383 | -26.9% | 0.00% | 0.0% |
Q2 2022 | $1,499,000 | +154.9% | 602,205 | +399.9% | 0.00% | – |
Q1 2022 | $588,000 | -54.5% | 120,470 | +5.5% | 0.00% | -100.0% |
Q4 2021 | $1,292,000 | +7.4% | 114,204 | +38.3% | 0.00% | 0.0% |
Q3 2021 | $1,203,000 | -55.0% | 82,553 | -64.0% | 0.00% | -50.0% |
Q2 2021 | $2,672,000 | +179.5% | 229,333 | +192.6% | 0.00% | +100.0% |
Q1 2021 | $956,000 | -78.9% | 78,376 | -78.4% | 0.00% | -66.7% |
Q4 2020 | $4,535,000 | +67.0% | 362,523 | +100.9% | 0.00% | 0.0% |
Q3 2020 | $2,716,000 | -50.0% | 180,465 | -18.6% | 0.00% | -57.1% |
Q2 2020 | $5,431,000 | +4541.9% | 221,583 | +1491.3% | 0.01% | – |
Q3 2019 | $117,000 | +36.0% | 13,925 | +25.5% | 0.00% | – |
Q1 2019 | $86,000 | – | 11,098 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |